We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
VPS50
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • VPS50
CELL LINE
BILE DUCT CANCER BLADDER CANCER BONE CANCER BRAIN CANCER BREAST CANCER CERVICAL CANCER COLORECTAL CANCER ESOPHAGEAL CANCER GALLBLADDER CANCER GASTRIC CANCER
HEAD AND NECK CANCER KIDNEY CANCER LEUKEMIA LIVER CANCER LUNG CANCER LYMPHOMA MYELOMA NEUROBLASTOMA NON-CANCEROUS OVARIAN CANCER
PANCREATIC CANCER PROSTATE CANCER RHABDOID SARCOMA SKIN CANCER TESTIS CANCER THYROID CANCER UNCATEGORIZED UTERINE CANCER
Human cell lines
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

VPS50
Gene descriptioni

Full gene name according to HGNC.

VPS50 subunit of EARP/GARPII complex
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

6
HUMAN PROTEIN ATLAS INFORMATIONi

Summary of RNA expression based on cell line data from the DepMap portal and cell line data generated within the Human Protein Atlas project.

Cell line expression clusteri

The RNA data was used to cluster genes according to their expression across cell lines. Clusters contain genes that have similar expression patterns, and each cluster has been manually annotated to describe common features in terms of function and specificity.

Read more
Non-specific - Transcription (mainly)
Cell line specificityi

RNA specificity category based on RNA sequencing data from cancer cell lines in the Human Protein Atlas grouped according to type of cancer. Genes are classified into six different categories (enriched, group enriched, enhanced, low specificity and not detected) according to their RNA expression levels across the panel of cell lines.

Read more
Low cancer specificity
Tau specificity scorei

Tau specificity score is a numerical indicator of the specificity of the gene expression across cells or tissues. The value ranges from 0 and 1, where 0 indicates identical expression across all cells/tissue types, while 1 indicates expression in a single cell/tissue type.

Read more
0.18
Cell line distributioni

RNA distribution category based on RNA sequencing data from cancer cell lines in the Human Protein Atlas grouped according to type of cancer. Genes are classified into five different categories (detected in all, detected in many, detected in some, detected in single and not detected) according to their pattern of detected RNA expression across the panel of cell lines.

Read more
Detected in all
Protein evidencei

Evidence score for genes based on UniProt protein existence (UniProt evidence); a Human Protein Atlas antibody- or RNA based score (HPA evidence); and evidence based on PeptideAtlas (MS evidence). The avaliable scores are evidence at protein level, evidence at transcript level, no evidence, or not avaliable.

Read more
Evidence at protein level
CELL LINESi

RNA expression data as normalized transcript per million (nTPM) values of cancer cell lines.The analyzed cell lines are grouped according to cancer type. Detailed information about the groups is revealed by hovering over the corresponding bar in the chart. More information and cell line data can be found in the Cell line section.

Read more
Cell line categories
Alphabetical
Expression
RNA specificity:Low cancer specificity

EXPRESSION CLUSTERING & CORRELATIONi

The RNA data was used to cluster genes according to their expression across samples. The resulting clusters have been manually annotated to describe common features in terms of function and specificity. The annotation of the cluster is displayed together with a confidence score of the gene's assignment to the cluster. The confidence is calculated as the fraction of times the gene was assigned to this cluster in repeated calculations and is reported between 0 to 1, where 1 is the highest possible confidence. The clustering results are shown in a UMAP, where the cluster this gene was assigned to is highlighted as a colored area in which most of the cluster genes reside. A table shows the 15 most similar genes in terms of expression profile.

Read more
VPS50 is part of cluster 31 Non-specific - Transcription with confidencei

Confidence is the fraction of times a gene was assigned to the cluster in repeated clustering, and therefore reflects how strongly associated it is to the cluster. A confidence of 1 indicates that the gene was assigned to this cluster in all repeated clusterings.

Read more
1
223 genes in cluster
Go to interactive expression cluster page
15 nearest neighbours based on cell line RNA expression
Neighbouri

Gene name according to HGNC.

Descriptioni

Gene description according to HGNC.

Correlationi

Correlation between the selected gene and neighboring gene. Correlation is calculated as Spearman correlation in PCA space based on the RNA-seq expression data.

Read more
Clusteri

ID of the expression cluster of the neighboring gene.

Read more
RINT1 RAD50 interactor 1 0.6585 31
KRIT1 KRIT1 ankyrin repeat containing 0.6326 31
RBM48 RNA binding motif protein 48 0.6311 31
PEX1 Peroxisomal biogenesis factor 1 0.6265 31
ANKIB1 Ankyrin repeat and IBR domain containing 1 0.6245 31
CRCP CGRP receptor component 0.6211 31
RSBN1L Round spermatid basic protein 1 like 0.6172 31
WASL WASP like actin nucleation promoting factor 0.6164 31
ARPC1A Actin related protein 2/3 complex subunit 1A 0.6106 31
ING3 Inhibitor of growth family member 3 0.5995 31
PMPCB Peptidase, mitochondrial processing subunit beta 0.5782 31
METTL2B Methyltransferase like 2B 0.5721 31
GTPBP10 GTP binding protein 10 0.5699 31
ZKSCAN5 Zinc finger with KRAB and SCAN domains 5 0.5678 31
DUS4L Dihydrouridine synthase 4 like 0.5581 31

CELL LINE DATA
Alphabetical
Expression
Bile duct cancer (n=7)
Alphabetical
Expression
Bladder cancer (n=26)
Alphabetical
Expression
Bone cancer (n=19)
Alphabetical
Expression
Brain cancer (n=65)
Alphabetical
Expression
Breast cancer (n=50)
Alphabetical
Expression
Cervical cancer (n=3)
Alphabetical
Expression
Colorectal cancer (n=57)
Alphabetical
Expression
Esophageal cancer (n=27)
Alphabetical
Expression
Gallbladder cancer (n=1)
Alphabetical
Expression
Gastric cancer (n=38)
Alphabetical
Expression
Head and Neck cancer (n=33)
Alphabetical
Expression
Kidney cancer (n=31)
Alphabetical
Expression
Leukemia (n=88)
Alphabetical
Expression
Liver cancer (n=24)
Alphabetical
Expression
Lung cancer (n=196)
Alphabetical
Expression
Lymphoma (n=57)
Alphabetical
Expression
Myeloma (n=34)
Alphabetical
Expression
Neuroblastoma (n=17)
Alphabetical
Expression
Non-cancerous (n=60)
Alphabetical
Expression
Ovarian cancer (n=46)
Alphabetical
Expression
Pancreatic cancer (n=41)
Alphabetical
Expression
Prostate cancer (n=7)
Alphabetical
Expression
Rhabdoid (n=14)
Alphabetical
Expression
Sarcoma (n=14)
Alphabetical
Expression
Skin cancer (n=50)
Alphabetical
Expression
Testis cancer (n=1)
Alphabetical
Expression
Thyroid cancer (n=11)
Alphabetical
Expression
Uncategorized (n=10)
Alphabetical
Expression
Uterine cancer (n=28)

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.